<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>D’yakonov, Vladimir A.</author>
     <author>Kadikova, Gulnara N.</author>
     <author>Dzhemileva, Lilya U.</author>
     <author>Gazizullina, Guzel F.</author>
     <author>Ramazanov, Ilfir R.</author>
     <author>Dzhemilev, Usein M.</author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2017</year>
    <pub-dates>
     <date>2018-03-12</date>
    </pub-dates>
   </dates>
   <doi>10.1021/acs.joc.6b02540</doi>
   <abstract>A new, effective catalytic system based on Co(acac)2 has been developed for [6 + 2] cycloaddition of terminal alkynes to 1,3,5,7-cyclooctatetraene to give substituted bicyclo[4.2.2]deca-2,4,7,9-tetraenes in high yields (68–85%). The electrophilic activation of double bonds in the bicyclic products with m-CPBA is an efficient method for the synthesis of substituted bicyclo[4.3.1]deca-2,4,8-triene-7,10-diols, which form the key structural moieties of numerous natural biologically active compounds. The structures of the obtained compounds were reliably proven by modern spectral methods and X-ray diffraction. The mechanism of the discovered rearrangement was studied both using deuterium-labeled bicyclo[4.2.2]deca-2,4,7,9-tetraenes and utilizing quantum chemical calculations. The obtained substituted bicyclo[4.3.1]deca-2,4,8-triene-7,10-diols and their keto derivatives showed high antitumor activity in vitro against Hek293, Jurkat, K562, and A549 tumor cell lines.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/956</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1084</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
